STOCK TITAN

CCCC (NASDAQ: CCCC) notice to sell 101,175 shares via option exercise on 03/09/2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CCCC submitted a Form 144 notice for the proposed sale of 101,175 shares of common stock via a stock option exercise to be effected on 03/09/2026. The filing also records a prior sale of 11,517 shares on 02/17/2026 with proceeds shown as $21,193.82.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists a planned sale of 101,175 shares tied to option exercise on 03/09/2026.

The notice identifies the method as a stock option exercise with cash proceeds and a filing date of 03/09/2026. Form 144 is a notice of proposed sale under Rule 144; it does not itself execute transactions.

Prior activity shows a sale of 11,517 shares on 02/17/2026 for $21,193.82. Subsequent SEC filings or broker reports will confirm execution and settlement details.

This filing documents a holder’s planned disposition; it is routine and administrative in nature.

The notice names the broker-dealer Morgan Stanley Smith Barney LLC and lists 101,175 shares to be sold. Rule-based disclosures like this inform market overhang but do not change corporate fundamentals by themselves.

Watch for follow-up filings reporting actual sale quantities and any changes in beneficial ownership; timing shown is 03/09/2026.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CCCC's Form 144 filed 03/09/2026 report?

It reports a proposed sale of 101,175 common shares via a stock option exercise scheduled for 03/09/2026. The filing is a regulatory notice of intent to sell under Rule 144, not a record of a completed trade.

Who is the broker handling the proposed sale in the CCCC Form 144?

The filing lists Morgan Stanley Smith Barney LLC as the broker-dealer associated with the transaction. The notice attributes the planned sale method as a stock option exercise to be settled for cash on 03/09/2026.

Does the Form 144 show any recent sales by insiders of CCCC?

Yes; the filing records a prior sale of 11,517 shares on 02/17/2026 with proceeds shown as $21,193.82. That entry reflects past disposition activity reported alongside the proposed sale.

Does filing Form 144 mean the shares have already been sold?

No. Form 144 is a notice of intent to sell under Rule 144; it does not confirm execution. Actual sales and settlement are reported separately if and when they occur in subsequent filings or broker reports.

What should investors look for after this Form 144 from CCCC?

Investors should look for follow-up disclosures that report execution or changes: subsequent Form 4 or broker confirmations will show actual sale quantities and any resulting changes in beneficial ownership after 03/09/2026.
C4 Therapeutics, Inc.

NASDAQ:CCCC

View CCCC Stock Overview

CCCC Rankings

CCCC Latest News

CCCC Latest SEC Filings

CCCC Stock Data

350.31M
86.26M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
WATERTOWN